CRSP position history
The shares of Crispr Therapeutics (CRSP) that ARK Investment Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 7,585,674 shares, $849M, 2.0% of portfolio
- 2021 Q4: 9,087,868 shares, $689M, 2.1% of portfolio, Add +19.8%
- 2022 Q1: 9,404,071 shares, $590M, 2.5% of portfolio, Add +3.5%
- 2022 Q2: 9,727,531 shares, $565M, 3.3% of portfolio, Add +3.4%
- 2022 Q3: 8,237,122 shares, $538M, 3.8% of portfolio, Reduce −15.3%
- 2022 Q4: 7,829,932 shares, $318M, 2.8% of portfolio, Reduce −4.9%
- 2023 Q1: 7,990,188 shares, $361M, 2.5% of portfolio, Add +2.0%
- 2023 Q2: 7,338,447 shares, $412M, 2.7% of portfolio, Reduce −8.2%
- 2023 Q3: 7,163,118 shares, $325M, 2.5% of portfolio, Reduce −2.4%
- 2023 Q4: 8,536,104 shares, $534M, 3.2% of portfolio, Add +19.2%
- 2024 Q1: 8,157,028 shares, $556M, 3.8% of portfolio, Reduce −4.4%
- 2024 Q2: 7,778,536 shares, $420M, 3.7% of portfolio, Reduce −4.6%
- 2024 Q3: 7,498,625 shares, $352M, 3.2% of portfolio, Reduce −3.6%
- 2024 Q4: 8,973,064 shares, $353M, 2.9% of portfolio, Add +19.7%
- 2025 Q1: 10,165,400 shares, $346M, 3.5% of portfolio, Add +13.3%
- 2025 Q2: 10,182,590 shares, $495M, 3.6% of portfolio, Add +0.2%
- 2025 Q3: 9,786,973 shares, $634M, 3.8% of portfolio, Reduce −3.9%
- 2025 Q4: 10,522,057 shares, $552M, 3.7% of portfolio, Add +7.5%
- 2026 Q1: 11,313,623 shares, $538M, 4.2% of portfolio, Add +7.5%
- 2026 Q2: 9,460,939 shares, $516M, 3.4% of portfolio, Reduce −16.4%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|